A Taste Assessment of BMS-986165 in Healthy Participants
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 25 - 80 |
| Updated: | 12/6/2018 |
| Start Date: | October 11, 2018 |
| End Date: | February 21, 2019 |
| Contact: | Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, |
| Email: | Clinical.Trials@bms.com |
| Phone: | please email: |
An Open-Label Taste Assessment of BMS-986165 in Healthy Participants
The purpose of this study is to assess the taste characteristics of BMS-986165 formulations,
alone and mixed, in order to develop a pediatric oral form of BMS-986165.
alone and mixed, in order to develop a pediatric oral form of BMS-986165.
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please
visit www.BMSStudyConnect.com
Inclusion Criteria:
- WOCBP must agree to follow instructions for method(s) of contraception for 5
half-lives of BMS-986165 (2 days) plus 30 days (duration of ovulatory cycle) for a
total of 32 days after each tasting day.
- Males who are sexually active with WOCBP must agree to follow instructions for
method(s) of contraception 5 half-lives of the study drug (2 days) after each tasting
day.
Exclusion Criteria:
- A known sensitivity to BMS-986165
- A history of any illness that, in the opinion of the investigator, might confound the
results of the study or pose an additional risk in administering study drug(s) to the
participant. This may include but is not limited to: a history of relevant drug or
food allergies; history of cardiovascular or central nervous system disease; history
or presence of clinically significant pathology; or history of mental disease
Other protocol defined inclusion/exclusion criteria could apply
We found this trial at
1
site
Click here to add this to my saved trials
